BSE

  • Swetsam Stock Holding sells 2 lakh shares of Relstruct Buildcon: Swetsam Stock Holding Private Limited sold 204,000 shares of Relstruct Buildcon at Rs 47.90 per share on the BSE. http://bit.ly/2tOVcAm

    submitted via moneycontrol , 1 day ago by StockNews filed under
  • Elgi Equipments#39; AGM on July 28, 2017: Elgi Equipments Ltd has informed BSE that the 57th Annual General Meeting (AGM) of the Company will be held on July 28, 2017. http://bit.ly/2tviT5L

    submitted via moneycontrol , 2 days ago by StockNews filed under
  • Suven Life secures neuro drug patent from Australia: The company has been granted one product patent from Australia corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases, it said in a BSE filing. http://bit.ly/2tw3e5V

    submitted via moneycontrol , 2 days ago by StockNews filed under
  • USFDA completed audit of Mexican plant: Dr Reddy#39;s Laboratories: "The audit of our API Cuernavaca plant in Mexico by the USFDA has been completed with zero observations," Dr Reddy#39;s Laboratories (DRL) said in a BSE filing. http://bit.ly/2tlf92v

    submitted via moneycontrol , 2 days ago by StockNews filed under
  • Wipro jumps 8% as board approves share buyback: Following the announcement, the stock jumped 8.17 per cent to hit a 52-week high of Rs 291 on BSE. http://bit.ly/2tvvtSl

    submitted via economic times , 2 days ago by StockNews filed under
  • Kotak Mahindra Bank to raise Rs 65,000 cr: The decision to this effect was taken in the Annual General Meeting held today in Mumbai, the bank said in a filing to BSE. http://bit.ly/2tv5XwA

    submitted via moneycontrol , 2 days ago by StockNews filed under
  • Typhoon Financial Services#39;s AGM on September 2017: Typhoon Financial Services Limited has informed BSE Limited that the 27th AGM of the Members of the Company will be convene on Wednesday, the 27th September, 2017 at 4.00 p.m. at the Registered Office of the Company at Ahmedabad. http://bit.ly/2ti7IsN

    submitted via moneycontrol , 3 days ago by StockNews filed under
  • DB Corp Q1 net rises 6% to Rs 110 cr: The company, which publishes Dainik Bhaskar newspaper, had posted a net profit of Rs 103.95 crore during the same quarter of previous fiscal, DB Corp informed BSE. http://bit.ly/2thLM0P

    submitted via moneycontrol , 3 days ago by StockNews filed under
  • Sensex flirts with 32K but nearly 100 stocks hit fresh 52-week high on the BSE: Banks are leading charge on the index with SP BSE Bankex rose over 0.57 percent, followed by BSE Realty index which was up 0.54 percent, and BSE Smallcap index gained 0.38 percent. http://bit.ly/2thAtWB

    submitted via moneycontrol , 3 days ago by StockNews filed under
  • M-cap of BSE companies soars to life high of Rs 131 lakh crore: Total market valuation of all listed companies on the BSE surged to a record high of over Rs 131 lakh crore on Wednesday brought about by upbeat sentiment in the broader market. http://bit.ly/2uaalQp

    submitted via moneycontrol , 4 days ago by StockNews filed under
  • Sensex rebounds 244 pts, Nifty ends tad below 9900; broader markets outperform: The BSE Midcap and Smallcap indices gained 1 percent each as about two shares advanced for every share falling on the exchange. http://bit.ly/2tG0fDj

    submitted via moneycontrol , 4 days ago by StockNews filed under
  • Tobacco stocks rebound after sharp plunge: The stock of ITC made a positive opening and gained 2.56 per cent to Rs 291.90 on the BSE. http://bit.ly/2u8Iu2M

    submitted via economic times , 4 days ago by StockNews filed under
  • Aurobindo Pharma gets USFDA nod to market kidney ailment drug: "The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Sevelamer Carbonate tablets 800 mg," Aurobindo Pharma said in a BSE filing today. http://bit.ly/2u9lwc1

    submitted via moneycontrol , 4 days ago by StockNews filed under
  • Zydus Cadila launches anti-ulcer drug in US: "Zydus Cadila has commercially launched its mesalamine delayed release tablets in the US market. Zydus was the first to file an Abbreviated New Drug Application (ANDA) for the generic version of Lialda," the company said in a BSE filing today. http://bit.ly/2u8MVLe

    submitted via moneycontrol , 4 days ago by StockNews filed under
  • TTK Prestige#39;s AGM on August 11, 2017: TTK Prestige Ltd has informed BSE that the 61st Annual General Meeting (AGM) of the Company will be held on August 11, 2017. http://bit.ly/2tEVaec

    submitted via moneycontrol , 4 days ago by StockNews filed under